scispace - formally typeset
R

Rafael Molina

Researcher at University of Granada

Publications -  398
Citations -  11970

Rafael Molina is an academic researcher from University of Granada. The author has contributed to research in topics: Image restoration & Iterative reconstruction. The author has an hindex of 52, co-authored 381 publications receiving 10765 citations. Previous affiliations of Rafael Molina include Intel & Northwestern University.

Papers
More filters
Journal ArticleDOI

Bayesian Compressive Sensing Using Laplace Priors

TL;DR: This paper model the components of the compressive sensing (CS) problem, i.e., the signal acquisition process, the unknown signal coefficients and the model parameters for the signal and noise using the Bayesian framework and develops a constructive (greedy) algorithm designed for fast reconstruction useful in practical settings.
Journal ArticleDOI

Using Deep Neural Networks for Inverse Problems in Imaging: Beyond Analytical Methods

TL;DR: The popular neural network architectures used for imaging tasks are reviewed, offering some insight as to how these deep-learning tools can solve the inverse problem.
Journal ArticleDOI

Clinical use of biomarkers in breast cancer: Updated guidelines from the European Group on Tumor Markers (EGTM).

TL;DR: In oestrogen receptor-positive, HER2-negative, lymph node-negative patients, multianalyte tests such as urokinase plasminogen activator (uPA)-PAI-1, Oncotype DX, MammaPrint, EndoPredict, Breast Cancer Index (BCI) and Prosigna (PAM50) may be used to predict outcome and aid adjunct therapy decision-making.
Journal ArticleDOI

Tumor markers in breast cancer- European Group on Tumor Markers recommendations.

TL;DR: Recommendations are presented for the routine clinical use of serum and tissue-based markers in the diagnosis and management of patients with breast cancer and recently validated prognostic markers for lymph node-negative breast cancer patients may be of value in selecting node- negative patients that do not require adjuvant chemotherapy.
Journal ArticleDOI

Tumor markers (CEA, CA 125, CYFRA 21-1, SCC and NSE) in patients with non-small cell lung cancer as an aid in histological diagnosis and prognosis: Comparison with the main clinical and pathological prognostic factors

TL;DR: All tumor markers showed a clear relationship with tumor stage and histology and therefore enabled a better histological diagnosis and helped in the diagnosis of non-small cell lung cancer.